These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 16477280)

  • 41. Drugs and their names.
    Drug Ther Bull; 2018 Mar; 56(3):33-36. PubMed ID: 29545265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prescription by INN (International Non-Proprietary Name)].
    Elsen C; Nève J; Schetgen M
    J Pharm Belg; 2005; 60(3):77-83. PubMed ID: 16252508
    [No Abstract]   [Full Text] [Related]  

  • 43. Choice of generic versus brand-name antidepressants in a regulated prescription drug market: evidence from Taiwan.
    Liu YM; Ou HT; Yang YK
    J Ment Health Policy Econ; 2014 Dec; 17(4):163-72. PubMed ID: 25599280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies.
    Kersnik J; Peklar J
    J Clin Pharm Ther; 2006 Dec; 31(6):577-83. PubMed ID: 17176362
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prescription of generic drugs in general practice. Results of a survey of general practitioners].
    Simmenroth-Nayda A; Hummers-Pradier E; Ledig T; Jansen R; Niebling W; Bjerre LM; Kochen MM; Himmel W
    Med Klin (Munich); 2006 Sep; 101(9):705-10. PubMed ID: 16977394
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia.
    McManus P; Birkett DJ; Dudley J; Stevens A
    Pharmacoepidemiol Drug Saf; 2001; 10(4):295-300. PubMed ID: 11760489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trade name, INNs, and medication errors.
    Cohen MR
    Arch Intern Med; 2002 Dec 9-23; 162(22):2636; author reply 2636-7. PubMed ID: 12456253
    [No Abstract]   [Full Text] [Related]  

  • 48. What's in a name? Generics and the persistence of the pharmaceutical brand in American medicine.
    Greene JA
    J Hist Med Allied Sci; 2011 Oct; 66(4):468-506. PubMed ID: 20858701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Generic drug prescriptions following hospital discharge: a prospective study in France.
    Chu C; Rudant E; Bonvalet M; Agostini H; Cavalié P; Bonhomme-Faivre L; Frenkiel J; Taillandier J; Boissonnas A; Vittecoq D; Wyplosz B
    Eur J Intern Med; 2011 Oct; 22(5):e45-9. PubMed ID: 21925042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brand names, generic prescribing, and generic substitution.
    Pincus RC
    Med J Aust; 1983 Jul; 2(2):89-91. PubMed ID: 6679055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Patients' experiences with and attitudes to generic substitution].
    Kjønniksen I; Lindbaek M; Granås AG
    Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1682-4. PubMed ID: 15976842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prescription errors--dimension and measures].
    Haavik S; Horn AM; Mellbye KS; Kjønniksen I; Granås AG
    Tidsskr Nor Laegeforen; 2006 Jan; 126(3):296-8. PubMed ID: 16440032
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trade names and generic names. Problems for prescribing physicians.
    Hemminki E; Enlund H; Hellevuo K; Laurila R; Turakka H
    Scand J Prim Health Care; 1984 May; 2(2):84-7. PubMed ID: 6544453
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prescribing generic antiepileptic drugs: Issues and concerns for nurse practitioners.
    Barrett MW
    J Am Acad Nurse Pract; 2010 Jun; 22(6):300-4. PubMed ID: 20536627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patterns in spontaneous adverse event reporting among branded and generic antiepileptic drugs.
    Bohn J; Kortepeter C; Muñoz M; Simms K; Montenegro S; Dal Pan G
    Clin Pharmacol Ther; 2015 May; 97(5):508-17. PubMed ID: 25670505
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generic prescribing and substitution: the big issues.
    Duncan D
    Br J Community Nurs; 2010 May; 15(5):248-9. PubMed ID: 20453827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. By any other name: ambiguity in marketing proprietary anti-infective agents.
    Berger SA
    Clin Infect Dis; 2007 Jan; 44(1):65-8. PubMed ID: 17143817
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The importance of the physician in the generic versus trade-name prescription decision.
    Hellerstein JK
    Rand J Econ; 1998; 29(1):108-36. PubMed ID: 10182437
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How do drugs get their brand names?
    Novack GD
    Ocul Surf; 2012 Apr; 10(2):117-20. PubMed ID: 22482472
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.